EARLY ENDOSCOPIC CORRECTION OF VESICOURETERAL REFLUX IN CHILDREN WITH SPINA BIFIDA

Cover Page


Cite item

Abstract

The article discussed preliminary results of endoscopic correction of vesicoureteral reflux in children using polyacrylate polyalcohol copolymer (Vantris). Injections of polyacrylate polyalcohol copolymer were distributed to 33 patients of the urology department of the Filatov Pediatric Hospital between 2009 and 2014. There were 18 boys and 15 girls of average age of 3.5 years (between 3 months and 16 years). Fourteen patients had bilateral reflux (42.4%) and nineteen patients had unilateral reflux (57.6%). There were 47 injected ureters. Eighteen patients had IV grade reflux (38.9%), 22 patients had III grade reflux (46.2%), and seven patients had II grade reflux (14.9%). Injected volume per unit was 0,76 ± 0,43 ml. Follow up median was 20 months. Reflux was eliminated in 38 renal units (76.7%), decreased to grade I-II in 9 (19.1%) and persisted in 1 (2.2%). One patient experienced uretral obstruction (2.2%). It was treated with Cohen transtrigonal ureteric reimplantation surgery. Overall success level was 95.6%.

About the authors

A. M. Shamsiev

Samarkand State Medical Institute

Author for correspondence.
Email: noemail@neicon.ru
Russian Federation

B. P. Aliev

Samarkand State Medical Institute; Pirogov Russian National Research Medical University

Email: noemail@neicon.ru
Russian Federation

S. N. Nikolaev

Pirogov Russian National Research Medical University

Email: noemail@neicon.ru
Russian Federation

References

  1. Ахунзянов А.А., Байбиков Р.С., Тахаутдинов Ш.К. Эндоскопические методы лечения пузырно-мочеточникового рефлюкса у детей // Нижегородский медицинский журнал. 2004. С. 106.
  2. Заугаров М.Ю. Эндоскопическая коррекция пузырно-мочеточникового рефлюкса у детей: дис. … канд. мед. наук. - Уфа, 2008. - 94 с.
  3. Текотов А.Н. Дифференцированный подход к выбору эндоскопического импланта в лечении пузырно-мочеточникового рефлюкса у детей: дис….. канд. мед. наук. - М., 2012. - 274 с.
  4. Aaronson D.S., Siddiqui S.A. et al. Relative Contraindication to Endoscopic Subureteral Injection for Vesicoureteral Reflux: Congenital Refluxing Megaureter with Distal Aperistaltic Segment // Urology. 2008. Vol. 71. P. 216.
  5. Chertin B., Kocherov S. Endoscopic treatment of primary grades IV and V vesicoureteral reflux in children with subureteral injection of polytetrafluoroethylene // J. Ped. Urol. 2010. Vol. 6. No 3. P. 251.
  6. Chi A., Gupta A., Snodgras W. Urinary tract infection following successful dextranomer/hyaluronic acid injection for vesicoureteral reflux // J. Urol. 2008. Vol. 179. N 5. P. 1966-1969.
  7. Elder J.S., Diaz M. et al. Endoscopic therapy for vesicoureteral reflux: a metaanalysis // J. Urol. 2006. Vol. 175. P. 716.
  8. Lackgren G., Wahlin N. et al. Endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid copolymer is effective in either double ureters or a small kidney // J. Urol. 2001. Vol. 166. P. 1887.
  9. Lee E.K., Gatti J.M. et al. Long-term followup of dextranomer/hyaluronic acid injection for vesicoureteral reflux: late failure warrants continued followup // J. Urol. 2009. Vol. 181. P. 1869.
  10. Matouschek E. // J. Urol. 1981. Vol. 20. P. 263.
  11. Ormaechea M., Paladini M. et al. New tissue bulking agent (polyacrylate polyalcohol) for treating vesicoureteral reflux: preliminary results in children // Arch. Esp. Urol. 2008. Vol. 61. Р. 263.
  12. Puri P., Chertin B., Dass L. et al. Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic acid copolymer: preliminary results // J. Urol. 2003. Vol. 170. No 4. P. 1541-1544.
  13. Paladini M., Sambuelli M. et al. Vantris® una sustancia inyectable biocompatible, sintética, no biodegradable y fácil de aplicar: Evaluación de la reacción tisular local, y de la migración local y a larga distancia // Arch. Esp. Urol. 2008. Vol. 61. P. 269.

Copyright (c) 2015 Shamsiev A.M., Aliev B.P., Nikolaev S.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies